Two studies were included in the newly diagnosed type 2 diabetes subgroup [8, 9], and these patients showed increased nesfatin-1 levels compared with control subjects [MD = 0.59; 95% CI (0.45 and 0.74), P < 0.00001, I2 = 13%]. The gene discussed is NUCB2; the disease is type 2 diabetes mellitus.